{"transactions":[{"id":678815,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-08-21T20:35:09.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund."}],"balance_after":12745,"source":{"system":"sec-edgar","filing":"0001384243-26-000014","document":"form4-08212026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000014/form4-08212026_080804.xml","form_type":"4"}},{"id":754862,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754861,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754860,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12185,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":754859,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:52:27.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001384243-26-000012","document":"form4-06022026_080623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000012/form4-06022026_080623.xml","form_type":"4"}},{"id":797962,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-04-29T20:46:07.000Z","date":"2026-04-28","kind":"exercise","planned":true,"acquired":false,"shares":13099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":13237,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Ordinary Shares","underlying_shares":13099},"source":{"system":"sec-edgar","filing":"0001384243-26-000010","document":"form4-04292026_080403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000010/form4-04292026_080403.xml","form_type":"4"}},{"id":797961,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-04-29T20:46:07.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":13099,"price":50.1,"value":656259.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.725. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000010","document":"form4-04292026_080403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000010/form4-04292026_080403.xml","form_type":"4"}},{"id":797960,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-04-29T20:46:07.000Z","date":"2026-04-28","kind":"exercise","planned":true,"acquired":true,"shares":13099,"price":14.33,"value":187708.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":25645,"source":{"system":"sec-edgar","filing":"0001384243-26-000010","document":"form4-04292026_080403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000010/form4-04292026_080403.xml","form_type":"4"}},{"id":812556,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-04-08T20:34:47.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":6901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":26336,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Ordinary Shares","underlying_shares":6901},"source":{"system":"sec-edgar","filing":"0001384243-26-000008","document":"form4-04082026_080443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000008/form4-04082026_080443.xml","form_type":"4"}},{"id":812555,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:34:47.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":6901,"price":50,"value":345050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.015. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000008","document":"form4-04082026_080443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000008/form4-04082026_080443.xml","form_type":"4"}},{"id":812554,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:34:47.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":6901,"price":14.33,"value":98891.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":19447,"source":{"system":"sec-edgar","filing":"0001384243-26-000008","document":"form4-04082026_080443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000008/form4-04082026_080443.xml","form_type":"4"}},{"id":907648,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-02-12T21:34:44.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":2690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":2690},"source":{"system":"sec-edgar","filing":"0001384243-26-000004","document":"form4-02122026_090237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000004/form4-02122026_090237.xml","form_type":"4"}},{"id":907647,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-02-12T21:34:44.000Z","date":"2026-02-10","kind":"exercise","planned":true,"acquired":false,"shares":110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":2690,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":110},"source":{"system":"sec-edgar","filing":"0001384243-26-000004","document":"form4-02122026_090237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000004/form4-02122026_090237.xml","form_type":"4"}},{"id":907646,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-12T21:34:44.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":2690,"price":45,"value":121050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000004","document":"form4-02122026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000004/form4-02122026_090237.xml","form_type":"4"}},{"id":907645,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-12T21:34:44.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":2690,"price":15.47,"value":41614.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":15236,"source":{"system":"sec-edgar","filing":"0001384243-26-000004","document":"form4-02122026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000004/form4-02122026_090237.xml","form_type":"4"}},{"id":907644,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-12T21:34:44.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":110,"price":45,"value":4950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000004","document":"form4-02122026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000004/form4-02122026_090237.xml","form_type":"4"}},{"id":907643,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-12T21:34:44.000Z","date":"2026-02-10","kind":"exercise","planned":true,"acquired":true,"shares":110,"price":15.47,"value":1701.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":12656,"source":{"system":"sec-edgar","filing":"0001384243-26-000004","document":"form4-02122026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000004/form4-02122026_090237.xml","form_type":"4"}},{"id":919462,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":false,"shares":2602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":2800,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":2602},"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919461,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-03","kind":"exercise","planned":true,"acquired":false,"shares":12528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":5402,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12528},"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919460,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":17930,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":830},"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919459,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":2602,"price":45.02,"value":117142.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.05. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919458,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":true,"shares":2602,"price":15.47,"value":40252.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":15148,"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919457,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":12528,"price":45.27,"value":567142.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.48. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919456,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-03","kind":"exercise","planned":true,"acquired":true,"shares":12528,"price":15.47,"value":193808.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":25074,"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919455,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":830,"price":45,"value":37350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.02. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":919454,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:24:23.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":830,"price":15.47,"value":12840.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":13376,"source":{"system":"sec-edgar","filing":"0001384243-26-000002","document":"form4-02042026_110219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424326000002/form4-02042026_110219.xml","form_type":"4"}},{"id":965097,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-12-17T21:38:32.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":20129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.36,"expiration_date":"2028-02-29","underlying":"Class A Ordinary Shares","underlying_shares":20129},"source":{"system":"sec-edgar","filing":"0001384243-25-000004","document":"form4-12172025_091228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424325000004/form4-12172025_091228.xml","form_type":"4"}},{"id":965096,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-12-17T21:38:32.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":20129,"price":41.51,"value":835554.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.19 and $41.78. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001384243-25-000004","document":"form4-12172025_091228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424325000004/form4-12172025_091228.xml","form_type":"4"}},{"id":965095,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-12-17T21:38:32.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":20129,"price":10.36,"value":208536.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025."}],"balance_after":32675,"source":{"system":"sec-edgar","filing":"0001384243-25-000004","document":"form4-12172025_091228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000138424325000004/form4-12172025_091228.xml","form_type":"4"}},{"id":1115049,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-11","kind":"exercise","planned":false,"acquired":false,"shares":12336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Shares","underlying_shares":12336},"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115048,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":false,"shares":8212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":12336,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Shares","underlying_shares":8212},"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115047,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":20548,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Share","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115046,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-11","kind":"sale","planned":false,"acquired":false,"shares":12336,"price":30.39,"value":374891.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.28 and $30.5801. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115045,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-11","kind":"exercise","planned":false,"acquired":true,"shares":12336,"price":3.8,"value":46876.8,"ownership":{"direct":true},"balance_after":24882,"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115044,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-10","kind":"sale","planned":false,"acquired":false,"shares":8212,"price":30.36,"value":249316.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.00 and $30.52. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115043,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":true,"shares":8212,"price":3.8,"value":31205.6,"ownership":{"direct":true},"balance_after":20758,"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115042,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":6900,"price":30.26,"value":208794.0,"ownership":{"direct":true},"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1115041,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-11T21:35:55.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":true,"shares":6900,"price":3.8,"value":26220.0,"ownership":{"direct":true},"balance_after":19446,"source":{"system":"sec-edgar","filing":"0001415889-25-016724","document":"form4-06112025_090650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925016724/form4-06112025_090650.xml","form_type":"4"}},{"id":1121403,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T20:53:23.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-25-015784","document":"form4-06052025_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015784/form4-06052025_080657.xml","form_type":"4"}},{"id":1121402,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T20:53:23.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":2799,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001415889-25-015784","document":"form4-06052025_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015784/form4-06052025_080657.xml","form_type":"4"}},{"id":1121401,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-05T20:53:23.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":16798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":16798,"derivative":{"exercise_price":29.11,"expiration_date":"2035-06-02","underlying":"Class A Ordinary Shares","underlying_shares":16798},"source":{"system":"sec-edgar","filing":"0001415889-25-015784","document":"form4-06052025_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015784/form4-06052025_080657.xml","form_type":"4"}},{"id":1121400,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-05T20:53:23.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-015784","document":"form4-06052025_080657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015784/form4-06052025_080657.xml","form_type":"4"}},{"id":1486884,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:35:08.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-24-015994","document":"form4-06072024_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015994/form4-06072024_080604.xml","form_type":"4"}},{"id":1486883,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:35:08.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."}],"balance_after":3173,"derivative":{"underlying":"Class A Common Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-24-015994","document":"form4-06072024_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015994/form4-06072024_080604.xml","form_type":"4"}},{"id":1486882,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2024-06-07T20:35:08.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":19040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024."}],"balance_after":19040,"derivative":{"exercise_price":19.71,"expiration_date":"2034-06-04","underlying":"Class A Common Shares","underlying_shares":19040},"source":{"system":"sec-edgar","filing":"0001415889-24-015994","document":"form4-06072024_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015994/form4-06072024_080604.xml","form_type":"4"}},{"id":1486881,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2024-06-07T20:35:08.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":9373,"source":{"system":"sec-edgar","filing":"0001415889-24-015994","document":"form4-06072024_080604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015994/form4-06072024_080604.xml","form_type":"4"}},{"id":1839761,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-07-03T20:15:04.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-23-010559","document":"form4-07032023_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010559/form4-07032023_040701.xml","form_type":"4"}},{"id":1839760,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2023-07-03T20:15:04.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-23-010559","document":"form4-07032023_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010559/form4-07032023_040701.xml","form_type":"4"}},{"id":1862467,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-08T20:21:33.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."}],"balance_after":4373,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-23-009426","document":"form4-06082023_080630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009426/form4-06082023_080630.xml","form_type":"4"}},{"id":1862466,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2023-06-08T20:21:33.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":26236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023."}],"balance_after":26236,"derivative":{"exercise_price":15.19,"expiration_date":"2033-06-05","underlying":"Class A Common Shares","underlying_shares":26236},"source":{"system":"sec-edgar","filing":"0001415889-23-009426","document":"form4-06082023_080630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009426/form4-06082023_080630.xml","form_type":"4"}},{"id":2050108,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-20T22:10:01.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":850000,"derivative":{"exercise_price":3.13,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001209191-23-004303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123004303/doc4.xml","form_type":"4"}},{"id":2054185,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:36:40.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":16122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":114807,"derivative":{"underlying":"Common Stock","underlying_shares":16122},"source":{"system":"sec-edgar","filing":"0001209191-23-003563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003563/doc4.xml","form_type":"4"}},{"id":2054184,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:36:40.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":3645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":25521,"derivative":{"underlying":"Common Stock","underlying_shares":3645},"source":{"system":"sec-edgar","filing":"0001209191-23-003563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003563/doc4.xml","form_type":"4"}},{"id":2054183,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:40.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":5219,"price":3.17,"value":16544.23,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":177989,"source":{"system":"sec-edgar","filing":"0001209191-23-003563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003563/doc4.xml","form_type":"4"}},{"id":2054182,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:40.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":16122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":183208,"source":{"system":"sec-edgar","filing":"0001209191-23-003563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003563/doc4.xml","form_type":"4"}},{"id":2054181,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:40.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":3645,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":167086,"source":{"system":"sec-edgar","filing":"0001209191-23-003563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003563/doc4.xml","form_type":"4"}},{"id":2054180,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:40.000Z","date":"2022-10-31","kind":"other","acquired":true,"shares":1655,"price":3.2725,"value":5415.9875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2022."}],"balance_after":163441,"source":{"system":"sec-edgar","filing":"0001209191-23-003563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003563/doc4.xml","form_type":"4"}},{"id":2100100,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2022-12-01T21:16:00.000Z","date":"2022-11-29","kind":"exercise","acquired":false,"shares":21959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2025-12-15","underlying":"Class A Common Share","underlying_shares":21959},"source":{"system":"sec-edgar","filing":"0001415889-22-011878","document":"form4-12012022_091249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922011878/form4-12012022_091249.xml","form_type":"4"}},{"id":2100099,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2022-12-01T21:16:00.000Z","date":"2022-11-29","kind":"sale","acquired":false,"shares":21959,"price":16.15,"value":354637.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $16.09 to $16.25. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Class A Common Shares sold at each price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-011878","document":"form4-12012022_091249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922011878/form4-12012022_091249.xml","form_type":"4"}},{"id":2100098,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2022-12-01T21:16:00.000Z","date":"2022-11-29","kind":"exercise","acquired":true,"shares":21959,"price":1.59,"value":34914.81,"ownership":{"direct":true},"balance_after":21959,"source":{"system":"sec-edgar","filing":"0001415889-22-011878","document":"form4-12012022_091249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922011878/form4-12012022_091249.xml","form_type":"4"}},{"id":2136694,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:38:04.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":16122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":130929,"derivative":{"underlying":"Common Stock","underlying_shares":16122},"source":{"system":"sec-edgar","filing":"0001209191-22-053835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053835/doc4.xml","form_type":"4"}},{"id":2136693,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:38:04.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":29166,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-22-053835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053835/doc4.xml","form_type":"4"}},{"id":2136692,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:38:04.000Z","date":"2022-10-13","kind":"tax_withholding","acquired":false,"shares":5219,"price":3.76,"value":19623.44,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":161786,"source":{"system":"sec-edgar","filing":"0001209191-22-053835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053835/doc4.xml","form_type":"4"}},{"id":2136691,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:38:04.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":16122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":167005,"source":{"system":"sec-edgar","filing":"0001209191-22-053835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053835/doc4.xml","form_type":"4"}},{"id":2136690,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:38:04.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":150883,"source":{"system":"sec-edgar","filing":"0001209191-22-053835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053835/doc4.xml","form_type":"4"}},{"id":2207303,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:57:44.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":16122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":147051,"derivative":{"underlying":"Common Stock","underlying_shares":16122},"source":{"system":"sec-edgar","filing":"0001209191-22-042262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042262/doc4.xml","form_type":"4"}},{"id":2207302,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:57:44.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":32812,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-22-042262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042262/doc4.xml","form_type":"4"}},{"id":2207301,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:57:44.000Z","date":"2022-07-13","kind":"tax_withholding","acquired":false,"shares":5219,"price":3.01,"value":15709.19,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":147237,"source":{"system":"sec-edgar","filing":"0001209191-22-042262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042262/doc4.xml","form_type":"4"}},{"id":2207300,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:57:44.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":16122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":152456,"source":{"system":"sec-edgar","filing":"0001209191-22-042262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042262/doc4.xml","form_type":"4"}},{"id":2207299,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:57:44.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":136334,"source":{"system":"sec-edgar","filing":"0001209191-22-042262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042262/doc4.xml","form_type":"4"}},{"id":2207298,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:57:44.000Z","date":"2022-04-29","kind":"other","acquired":true,"shares":1504,"price":3.842,"value":5778.368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 29, 2022."}],"balance_after":132688,"source":{"system":"sec-edgar","filing":"0001209191-22-042262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042262/doc4.xml","form_type":"4"}},{"id":2218742,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-30T20:22:01.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."}],"balance_after":5000,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-22-007108","document":"form4-06302022_010649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007108/form4-06302022_010649.xml","form_type":"4"}},{"id":2218741,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2022-06-30T20:22:01.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2022."}],"balance_after":30000,"derivative":{"exercise_price":9.88,"expiration_date":"2032-06-28","underlying":"Class A Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-007108","document":"form4-06302022_010649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007108/form4-06302022_010649.xml","form_type":"4"}},{"id":2296659,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:05:27.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":16122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":163173,"derivative":{"underlying":"Common Stock","underlying_shares":16122},"source":{"system":"sec-edgar","filing":"0001209191-22-024522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024522/doc4.xml","form_type":"4"}},{"id":2296658,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:05:27.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":36458,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-22-024522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024522/doc4.xml","form_type":"4"}},{"id":2296657,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:05:27.000Z","date":"2022-04-13","kind":"tax_withholding","acquired":false,"shares":5219,"price":6.07,"value":31679.33,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":131184,"source":{"system":"sec-edgar","filing":"0001209191-22-024522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024522/doc4.xml","form_type":"4"}},{"id":2296656,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:05:27.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":16122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":136403,"source":{"system":"sec-edgar","filing":"0001209191-22-024522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024522/doc4.xml","form_type":"4"}},{"id":2296655,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:05:27.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":120281,"source":{"system":"sec-edgar","filing":"0001209191-22-024522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024522/doc4.xml","form_type":"4"}},{"id":2435419,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:08:43.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":16122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":179295,"derivative":{"underlying":"Common Stock","underlying_shares":16122},"source":{"system":"sec-edgar","filing":"0001209191-22-003362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003362/doc4.xml","form_type":"4"}},{"id":2435418,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:08:43.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":40104,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-22-003362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003362/doc4.xml","form_type":"4"}},{"id":2435417,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:08:43.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":5219,"price":8.3,"value":43317.7,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":116635,"source":{"system":"sec-edgar","filing":"0001209191-22-003362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003362/doc4.xml","form_type":"4"}},{"id":2435416,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:08:43.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":16122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":121854,"source":{"system":"sec-edgar","filing":"0001209191-22-003362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003362/doc4.xml","form_type":"4"}},{"id":2435415,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:08:43.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":105732,"source":{"system":"sec-edgar","filing":"0001209191-22-003362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003362/doc4.xml","form_type":"4"}},{"id":2542026,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:25:50.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":195417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":195417,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":195417},"source":{"system":"sec-edgar","filing":"0001209191-21-060551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060551/doc4.xml","form_type":"4"}},{"id":2542025,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-15T20:25:50.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":390834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant."}],"balance_after":390834,"derivative":{"exercise_price":10.55,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":390834},"source":{"system":"sec-edgar","filing":"0001209191-21-060551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060551/doc4.xml","form_type":"4"}},{"id":2542024,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:25:50.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":43750,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-21-060551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060551/doc4.xml","form_type":"4"}},{"id":2542023,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-15T20:25:50.000Z","date":"2021-10-13","kind":"tax_withholding","acquired":false,"shares":963,"price":10.55,"value":10159.65,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":102086,"source":{"system":"sec-edgar","filing":"0001209191-21-060551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060551/doc4.xml","form_type":"4"}},{"id":2542022,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-15T20:25:50.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":103049,"source":{"system":"sec-edgar","filing":"0001209191-21-060551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060551/doc4.xml","form_type":"4"}},{"id":2633550,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-15T20:50:34.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":3645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":47396,"derivative":{"underlying":"Common Stock","underlying_shares":3645},"source":{"system":"sec-edgar","filing":"0001209191-21-046790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046790/doc4.xml","form_type":"4"}},{"id":2633549,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:50:34.000Z","date":"2021-07-13","kind":"tax_withholding","acquired":false,"shares":963,"price":13.48,"value":12981.24,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":99403,"source":{"system":"sec-edgar","filing":"0001209191-21-046790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046790/doc4.xml","form_type":"4"}},{"id":2633548,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:50:34.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":3645,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":100366,"source":{"system":"sec-edgar","filing":"0001209191-21-046790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046790/doc4.xml","form_type":"4"}},{"id":2633547,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:50:34.000Z","date":"2021-04-30","kind":"other","acquired":true,"shares":1529,"price":13.8975,"value":21249.2775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021."}],"balance_after":96721,"source":{"system":"sec-edgar","filing":"0001209191-21-046790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046790/doc4.xml","form_type":"4"}},{"id":2650181,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2021-06-30T20:20:59.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":33237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021."}],"balance_after":33237,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Common Shares","underlying_shares":33237},"source":{"system":"sec-edgar","filing":"0001179110-21-007183","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021007183/edgar.xml","form_type":"4"}},{"id":2748989,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-15T20:54:50.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":51041,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-21-026844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026844/doc4.xml","form_type":"4"}},{"id":2748988,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:54:50.000Z","date":"2021-04-13","kind":"tax_withholding","acquired":false,"shares":963,"price":16.66,"value":16043.58,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock units to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":95192,"source":{"system":"sec-edgar","filing":"0001209191-21-026844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026844/doc4.xml","form_type":"4"}},{"id":2748987,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:54:50.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":96155,"source":{"system":"sec-edgar","filing":"0001209191-21-026844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026844/doc4.xml","form_type":"4"}},{"id":2748986,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:54:50.000Z","date":"2016-11-04","kind":"gift","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents transfer of shares by the reporting person's spouse to an account jointly held by the reporting person. The shares were inadvertently omitted from prior Form 5 filings."}],"balance_after":92509,"source":{"system":"sec-edgar","filing":"0001209191-21-026844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026844/doc4.xml","form_type":"4"}},{"id":2748985,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:54:50.000Z","date":"2016-11-04","kind":"gift","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents transfer of shares by the reporting person's spouse to an account jointly held by the reporting person. The shares were inadvertently omitted from prior Form 5 filings."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-026844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026844/doc4.xml","form_type":"4"}},{"id":2748984,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:54:50.000Z","date":"2015-06-20","kind":"other","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired indirect ownership of the shares upon marriage to the reporting person's spouse on June 20, 2015. The shares were inadvertently omitted from prior Form 4 filings."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001209191-21-026844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026844/doc4.xml","form_type":"4"}},{"id":2906641,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":20846,"kind":"person","name":"Quart Barry D","position":1,"cik":"0001384243","reported_name":"Quart Barry D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-15T21:29:29.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":3646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":54687,"derivative":{"underlying":"Common Stock","underlying_shares":3646},"source":{"system":"sec-edgar","filing":"0001209191-21-003804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003804/doc4.xml","form_type":"4"}}],"next_cursor":"2021-01-15T21:29:29.000000Z,2906641"}